Company profile: Simulations Plus
1.1 - Company Overview
Company description
- Provider of ADMET and pharmacometric modeling software, including GastroPlus for absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics across administration routes in humans and animals; ADMET Predictor for compound property prediction; PKPlus for PK/TK analysis and reporting; DDDPlus for simulating in vitro dissolution to predict in vivo performance; DILIsym for drug-induced liver injury modeling; and MonolixSuite for NLME modeling.
Products and services
- ADMET Predictor: Computational software that predicts absorption, distribution, metabolism, excretion, and toxicity properties of chemical compounds
- GastroPlus: Multi-route simulation software package that models absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics for humans and animals
- MonolixSuite: Nonlinear mixed-effects modeling suite that includes tools for data exploration, model building, and simulation.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Simulations Plus
Visiopharm
HQ: Denmark
Website
- Description: Provider of quantitative digital pathology image analysis and stereology software, including ONCOtopix Dx; APP Center with 130+ modular tissue analysis units; machine learning-based NerValence System for biomarker testing in neurodegenerative diseases; IVDR-cleared diagnostic algorithms and an IVDR-certified PD-L1 APP integrated into lab workflows and PACS/IMS; plus OBserver remote image viewing portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Visiopharm company profile →
Mytrus
HQ: United States
Website
- Description: Provider of clinical technology and services that enable people to safely participate in clinical trials from home, improving accessibility, convenience, and compliance while reducing costs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mytrus company profile →
Protein Mechanics
HQ: United States
Website
- Description: Provider of cross-disciplinary computational techniques to accelerate drug discovery and design, offering novel methods that enable physically accurate modeling of biomolecular systems at unprecedented speeds, with the aim of making in silico biology an everyday tool for medical researchers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protein Mechanics company profile →
ClinPhone
HQ: United Kingdom
Website
- Description: Provider of clinical technology, headquartered in Nottingham, United Kingdom, offering ClinPhone RTSM, part of the Perceptive MyTrials eClinical platform, for randomization and trial supply management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinPhone company profile →
Predictive Oncology
HQ: United States
Website
- Description: Provider of AI-driven oncology solutions for pharmaceutical, diagnostic, and biotech industries, including the PEDAL platform for drug-response prediction using a large tumor biobank; 3D tumor models for clinically relevant therapeutic testing; live-tumor drug-response and genomic biomarker testing; formulation services (solubility, stability, optimization) via high-throughput tech; and biologics development, purification, endotoxin detection/removal, and GMP manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Predictive Oncology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Simulations Plus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Simulations Plus
2.2 - Growth funds investing in similar companies to Simulations Plus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Simulations Plus
4.2 - Public trading comparable groups for Simulations Plus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →